Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+3.12M
-
Total reported value, excl. options
-
$21.6M
-
Value change
-
+$4.53M
-
Put/Call ratio
-
1.07
-
Number of buys
-
32
-
Number of sells
-
-27
-
Price
-
$1.92
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2022
67 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q2 2022.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 92.4M outstanding shares and own 12.15% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (5.04M shares), FMR LLC (1.6M shares), VANGUARD GROUP INC (1.01M shares), Point72 Asset Management, L.P. (754K shares), CVI Holdings, LLC (450K shares), ROYAL BANK OF CANADA (303K shares), Fosun International Ltd (282K shares), BlackRock Inc. (212K shares), BANK OF AMERICA CORP /DE/ (182K shares), and Steel Peak Wealth Management LLC (135K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.